Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Perioperative Negative Emotions in Breast Cancer Surgery Patients With Depression
NCT07374198Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2026
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of esketamine in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Perioperative anxiety and depression at day 30. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT07374198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07374198.